DIWALI SPECIAL

25% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim Offer →
logo

INDOKEM vs SUDARSHAN: Stock Comparison

INDOKEM vs SUDARSHAN PHARMA INDUpdated 13 Nov 26, 4:08 PM ISTNSE & company filings

SUDARSHAN PHARMA IND shows a lower P/E. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

INDOKEM leads 0; SUDARSHAN leads 5 of 9

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

INDOKEMSUDARSHAN

Valuation lens

What price are you paying?

Market CapContext only
₹1,798 Cr
₹0 Cr
P/E RatioSUDARSHAN has the lower reading
795.93x
28.27x ✓
P/B RatioSUDARSHAN has the lower reading
27.15x
4.11x ✓
EPSSUDARSHAN has the higher reading
₹0.15
₹0.32 ✓
Book ValueContext only
₹23.13
₹6.14
Dividend YieldSame reading
0%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

P/E Ratio
SUDARSHAN has a lower P/E
28.27x vs 795.93x
P/B Ratio
SUDARSHAN has a lower P/B
4.11x vs 27.15x
EPS
SUDARSHAN has higher earnings per share
₹0.32 vs ₹0.15
Qtr Sales Growth
SUDARSHAN has stronger quarterly sales growth
24.4% vs 1.33%
Qtr Profit Growth
SUDARSHAN has stronger quarterly profit growth
38.7% vs -59.81%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Price

MetricINDOKEMSUDARSHAN
Live Price₹634.75₹32.71
Day Change-0.88%0.03%
Volume9,83992,985
52-Week High₹770.95₹39.3
52-Week Low₹555₹31.01
Distance from 52W High-17.67%-16.77%

Valuation

MetricINDOKEMSUDARSHAN
Market Cap₹1,798 Cr₹0 Cr
P/E Ratio795.93x28.27x
P/B Ratio27.15x4.11x
EPS₹0.15₹0.32
Book Value₹23.13₹6.14
Dividend Yield0%0%

Growth

MetricINDOKEMSUDARSHAN
Revenue Growth (TTM YoY)0%0%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth1.33%24.4%
Qtr Profit Growth-59.81%38.7%

Profitability & Leverage

MetricINDOKEMSUDARSHAN
Net Margin0%0%

Shareholding

As of Sep 2026 • change vs previous quarter
MetricINDOKEMSUDARSHAN
Promoter Holding68.58%▼ 0.09 pp57.81%▼ 1.12 pp
FII Holding—21.95%▲ 2.57 pp
DII Holding0.19%0%
Public Holding31.22%▲ 0.08 pp20.19%▼ 1.45 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: INDOKEM and SUDARSHAN PHARMA IND.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.